BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38850800)

  • 1. Can thymosin beta 10 function both as a non-invasive biomarker and chemotherapeutic target in human colorectal cancer?
    Yang J; Yang X; Guo T; Wang L; Zhao Z; Hu Z; Li Y
    Transl Oncol; 2024 Aug; 46():102026. PubMed ID: 38850800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer.
    Zhang X; Ren D; Guo L; Wang L; Wu S; Lin C; Ye L; Zhu J; Li J; Song L; Lin H; He Z
    Breast Cancer Res; 2017 Feb; 19(1):15. PubMed ID: 28179017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNMT1 maintains the methylation of miR-152-3p to regulate TMSB10 expression, thereby affecting the biological characteristics of colorectal cancer cells.
    Wang C; Ma X; Zhang J; Jia X; Huang M
    IUBMB Life; 2020 Nov; 72(11):2432-2443. PubMed ID: 32918845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
    Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
    Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN/AKT upregulation of TMSB10 contributes to lung cancer cell growth and predicts poor survival of the patients.
    Li J; Zhou S; Li H; Xu Y; Zhou N; Liu R
    Biosci Biotechnol Biochem; 2021 Mar; 85(4):805-813. PubMed ID: 33686397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response.
    Li Z; Li Y; Tian Y; Li N; Shen L; Zhao Y
    Front Immunol; 2023; 14():1170539. PubMed ID: 37275863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMSB10, a potential prognosis prediction biomarker, promotes the invasion and angiogenesis of gastric cancer.
    Yan Z; Yan Q; Song Y; Wang L
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3102-3112. PubMed ID: 34114679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylation of the thymosin β(10) gene is not associated with its overexpression in non-small cell lung cancer.
    Lee SM; Na YK; Hong HS; Jang EJ; Yoon GS; Park JY; Kim DS
    Mol Cells; 2011 Oct; 32(4):343-8. PubMed ID: 22038593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin β10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K/Akt pathway in lung adenocarcinoma.
    Zeng J; Yang X; Yang L; Li W; Zheng Y
    Respir Res; 2020 Dec; 21(1):328. PubMed ID: 33349268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma.
    Xiong Y; Qi Y; Pan Z; Wang S; Li B; Feng B; Xue H; Zhao R; Li G
    Cancer Cell Int; 2022 Sep; 22(1):294. PubMed ID: 36163046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of thymosin β10 correlates with disease progression and poor prognosis in bladder cancer.
    Wang B; Wang Z; Zhang T; Yang G
    Exp Ther Med; 2019 Nov; 18(5):3759-3766. PubMed ID: 31616507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin β 10 is overexpressed and associated with unfavorable prognosis in hepatocellular carcinoma.
    Song C; Su Z; Guo J
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30787051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Relevance and Functional Implications of Thymosin Beta-10 in Glioma.
    Li W; Chen J; Xiang C; Long Y; Wu K; Li J
    Genet Res (Camb); 2023; 2023():5517445. PubMed ID: 38026448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deer thymosin beta 10 functions as a novel factor for angiogenesis and chondrogenesis during antler growth and regeneration.
    Zhang W; Chu W; Liu Q; Coates D; Shang Y; Li C
    Stem Cell Res Ther; 2018 Jun; 9(1):166. PubMed ID: 29921287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMSB10 Promotes Progression of Clear Cell Renal Cell Carcinoma via JUN Transcription Regulation.
    Wang C; He Y; You Z; Chen X
    Ann Clin Lab Sci; 2022 Mar; 52(2):230-239. PubMed ID: 35414502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMSB10 promotes migration and invasion of cancer cells and is a novel prognostic marker for renal cell carcinoma.
    Xiao R; Shen S; Yu Y; Pan Q; Kuang R; Huang H
    Int J Clin Exp Pathol; 2019; 12(1):305-312. PubMed ID: 31933746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymosin β10 mediates the effects of microRNA-184 in the proliferation and epithelial-mesenchymal transition of BCPAP cells.
    Yang C; Liu Y; Fang K
    Exp Ther Med; 2021 Jul; 22(1):742. PubMed ID: 34055058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymosin beta 10 loaded ZIF-8/sericin hydrogel promoting angiogenesis and osteogenesis for bone regeneration.
    Gao J; Ren J; Ye H; Chu W; Ding X; Ding L; Fu Y
    Int J Biol Macromol; 2024 May; 267(Pt 1):131562. PubMed ID: 38626832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosins β-4 and β-10 are expressed in bovine ovarian follicles and upregulated in cumulus cells during meiotic maturation.
    Salhab M; Papillier P; Perreau C; Guyader-Joly C; Dupont J; Mermillod P; Uzbekova S
    Reprod Fertil Dev; 2010; 22(8):1206-21. PubMed ID: 20883646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
    J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.